Oncology - Pancreatic Ca

Embed Size (px)

Citation preview

  • 7/28/2019 Oncology - Pancreatic Ca

    1/35

    ..

  • 7/28/2019 Oncology - Pancreatic Ca

    2/35

    232 ., 227 . 14900 , 14100 . 50 . - 0,97; 5- 3,8% 4,6% , - 5-20%.

    , . .

    30 .

  • 7/28/2019 Oncology - Pancreatic Ca

    3/35

    (, )

    10% ( ,

    -, -, BRCA2, ).

    Kras p53 .

  • 7/28/2019 Oncology - Pancreatic Ca

    4/35

    , .

    , , , , .

    , , 40 , 3,3 (95% CI:1,388,1). 2 , 15

    . () .

  • 7/28/2019 Oncology - Pancreatic Ca

    5/35

    -75%

    -18%

    -7%

  • 7/28/2019 Oncology - Pancreatic Ca

    6/35

    6 :

    -

    ( ) ( )

  • 7/28/2019 Oncology - Pancreatic Ca

    7/35

    :

    :

    ( )

    :

  • 7/28/2019 Oncology - Pancreatic Ca

    8/35

    0

    1 , 2 .

    2 , 2 .

    3 12-., , ( , ,

    , ( , , , , )

  • 7/28/2019 Oncology - Pancreatic Ca

    9/35

    Nx

    N0

    N1

    N1a

    N1b /

    0

    1

  • 7/28/2019 Oncology - Pancreatic Ca

    10/35

    1.

    - - - - ()

    - -

    2. 3. 4. 5. -

    6. - - -

    7. 8.

    9.

  • 7/28/2019 Oncology - Pancreatic Ca

    11/35

  • 7/28/2019 Oncology - Pancreatic Ca

    12/35

    1.

    2.

    3.

    4.

    5.

  • 7/28/2019 Oncology - Pancreatic Ca

    13/35

    1. , .

    2. . .

    3. .

    4. ( ) 70-80%.

  • 7/28/2019 Oncology - Pancreatic Ca

    14/35

    ().

    CA-19-9 (sialyl-Lewis-aantigen), .

    . ().

    ().

    ().

    . .

  • 7/28/2019 Oncology - Pancreatic Ca

    15/35

    .

    . .

  • 7/28/2019 Oncology - Pancreatic Ca

    16/35

    .

    .

  • 7/28/2019 Oncology - Pancreatic Ca

    17/35

    - ( )

    -- : , , .

  • 7/28/2019 Oncology - Pancreatic Ca

    18/35

  • 7/28/2019 Oncology - Pancreatic Ca

    19/35

    - -

    12 . (W. Molnar, A.E.Stockum, 1974 .)

  • 7/28/2019 Oncology - Pancreatic Ca

    20/35

    -

  • 7/28/2019 Oncology - Pancreatic Ca

    21/35

    )

  • 7/28/2019 Oncology - Pancreatic Ca

    22/35

    )

  • 7/28/2019 Oncology - Pancreatic Ca

    23/35

    . .

  • 7/28/2019 Oncology - Pancreatic Ca

    24/35

  • 7/28/2019 Oncology - Pancreatic Ca

    25/35

    ,

    . ,

    .

  • 7/28/2019 Oncology - Pancreatic Ca

    26/35

    , .

    :

    ,

    ,

    , .

  • 7/28/2019 Oncology - Pancreatic Ca

    27/35

    -

    ..

    -

    ..

  • 7/28/2019 Oncology - Pancreatic Ca

    28/35

  • 7/28/2019 Oncology - Pancreatic Ca

    29/35

    - , .

  • 7/28/2019 Oncology - Pancreatic Ca

    30/35

  • 7/28/2019 Oncology - Pancreatic Ca

    31/35

    1

    3

    ,

    4

    2 -

    6

    -

    5

    -

    7

    -

  • 7/28/2019 Oncology - Pancreatic Ca

    32/35

    . .. , ..

  • 7/28/2019 Oncology - Pancreatic Ca

    33/35

    .

    , .

    81%.

  • 7/28/2019 Oncology - Pancreatic Ca

    34/35

    5- ( 750,1000, 1250, 1500 mg/m2). 7 12.8 .

    (Gem+FU+LV) 11

    . 21 . (Pister et al., 2003). 4 ., - 7-8 ., 1 .

  • 7/28/2019 Oncology - Pancreatic Ca

    35/35

    36% 19% - 2 .

    3 25% , 50%, 10 . 1- 3 59% 21%, 11% 4 .

    4% 1 .